Tatum Anderson

Journalist, writer and editor

I have written science, technology, international development, business and travel articles for almost 20 years. More recently my focus has moved to global health.

I've written for newspapers, science, business and medical publications from The Lancet to the WHO Bulletin, The Economist, British Medical Journal, BBC News, Guardian, Intellectual Property Watch and Nature.

I am available for freelance commissions and will write features, white papers, supplements, reports and copy for internal magazines and websites.

Portfolio

A question of transparency
13 October 2016 Tatum Anderson looks at global efforts to enhance hospital pricing transparency In March this year, a group of 11 organisations - including one that represents...
Indian Company Moves To Provide Affordable Insulin Biosimilar In Europe As Patents Rise -...
by for Intellectual Property Watch Bangalore-based Biocon may become the first Indian company to offer a biosimilar insulin in Europe. And the patent and pricing story is...
Paediatric Cancer Drug Being Developed Entirely In The Open - Intellectual Property Watch
The term "Open" in science is all the rage these days. The Medicines for Malaria Venture (MMV) has posted a Malaria Box, containing over 400 compounds that might be effective...
EU Eyes Revamp Of Policy To Speed Drug Approvals In Developing Countries - Intellectual Property...
Article 58, a process introduced by the European Commission to help speed up the time low and middle-income countries take to approve new drugs, could be in for a massive...

All Copyrights Belong To Their Respective Owners